Sciencast Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,124
Closed -$277K 539
2021
Q2
$277K Buy
+6,124
New +$271K 0.06% 387
2020
Q4
Sell
-5,500
Closed -$219K 570
2020
Q3
$219K Buy
+5,500
New +$204K 0.08% 342
2020
Q2
Sell
-12,058
Closed -$318K 490
2020
Q1
$318K Buy
12,058
+4,858
+67% +$146K 0.09% 171
2019
Q4
$211K Buy
+7,200
New +$171K 0.06% 429
2019
Q3
Sell
-9,800
Closed -$233K 449
2019
Q2
$233K Buy
+9,800
New +$215K 0.13% 247

Other funds holding NEO

Sciencast Management's NEO Position: Q3 2021 in Review

Sciencast Management sold out of NeoGenomics (NEO) in Q3 2021, closing a stake of 6,124 shares — an estimated $277K sold.

Sciencast Management first reported a position in NEO in Q2 2019 and held it in 5 quarters. The position peaked at $318K in Q1 2020. 324 funds tracked by Wall St. Rank hold NEO as of Q3 2021.

  • Sciencast Management reported no remaining NeoGenomics position as of Q3 2021 after selling out during the quarter.
  • Sciencast Management sold 6,124 NeoGenomics shares in Q3 2021, an estimated $277K.
  • Sciencast Management first reported a position in NeoGenomics in Q2 2019 and held it in 5 quarters.
  • Sciencast Management's NeoGenomics position peaked at $318K in Q1 2020.
  • 324 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2021.

Based on Sciencast Management's 13F filing for Q3 2021, filed 21 Oct 2021.